SMMT
#841
Summit Therapeutics Inc. - Common Stock
14.3 7 USD
+0.01%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+1.48%
Variación mensual
+10.97%
Variación en los últimos 6 meses
-7.53%
Cambio anual
-27.64%
Cierres anteriores
14.1 6
Open
14.1 8
Mínimo
14.1 5
Máximo
14.7 2
Volumen
863
Financials
- Market Capitalization 11.46 B
- Employee 265
- Founded 2003
- CEO Robert DugganMaky Zanganeh
- Website www.smmttx.com
- Headquarter Florida, United States
- FIGI BBG00X3GQL76
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-13.13
Relación precio/flujo de caja
-17.12 K
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 803 |  CORT Corcept Therapeutics Incorporated - Common Stock | 113.39 USD | +0.01% | -7.29% | -0.67% | +54.55% | 12.26 B USD | ||
| 826 |  ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | 83.22 USD | +0.58% | -5.59% | -0.49% | +112.84% | 11.76 B USD | ||
| 845 |  TECH Bio-Techne Corp - Common Stock | 72.29 USD | +0.15% | -0.07% | +0.21% | +34.87% | 11.34 B USD | ||
| 861 |  KRYS Krystal Biotech, Inc. - Common Stock | 366.17 USD | +0.64% | +2.41% | +14.18% | +95.68% | 10.84 B USD |